Stock 6491 PEGAVISION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Pegavision Corporation Share Price Taipei Exchange

Equities

6491

TW0006491004

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 03/10/2019 BST 		5-day change 1st Jan Change
190 TWD -.--% Intraday chart for Pegavision Corporation -1.55% -.--%
01-29 Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Financials

Sales 2024 * 7.88B 242M 19.27B Sales 2025 * 8.72B 268M 21.33B Capitalization 40.33B 1.24B 98.64B
Net income 2024 * 2.02B 61.99M 4.93B Net income 2025 * 2.32B 71.28M 5.67B EV / Sales 2024 * 4.68 x
Net cash position 2024 * 3.49B 107M 8.53B Net cash position 2025 * 6.73B 207M 16.45B EV / Sales 2025 * 3.85 x
P/E ratio 2024 *
20 x
P/E ratio 2025 *
17.3 x
Employees -
Yield 2024 *
2.31%
Yield 2025 *
2.54%
Free-Float 52.23%
More Fundamentals * Assessed data

Chart Pegavision Corporation

Dynamic Chart

Latest news about Pegavision Corporation

Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pegavision Corporation announced that it expects to receive TWD 0.08 million in funding CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup DJ
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Pegavision Corporation Announces Appointment of Chi-Wan Lai as Member of 5th Compensation Committee CI
Pegavision Corporation Announces Appointment of Chi-Wan Lai as Member of Audit Committee CI
More news

Press releases Pegavision Corporation

Pegavision : The Company to attend the Online Investor Conference held by Masterlink Securities. PU
Pegavision : The Company to attend the Investor Conference held by Fubon Securities. PU
Pegavision : To announce that 2022Q2 consolidated financial statements reported to board of directors. PU
Pegavision : The Company cancels the Investor Conference held by KGI Securities. PU
Pegavision : The Company to attend the Investor Conference held by SinoPac Securities. PU
More press releases

News in other languages on Pegavision Corporation

Los ingresos de Pegavision podrían aumentar en junio -- Market Talk
More news

Managers and Directors - Pegavision Corporation

Managers TitleAgeSince
Te Sheng Yang CEO
 Chief Executive Officer - 13/06/18
Ching Hsiang Wang DFI
 Director of Finance/CFO - 26/12/13
Danny Peng IRC
 Investor Relations Contact - -
Members of the board TitleAgeSince
Tzu Hsien Tung BRD
 Director/Board Member 63 11/08/09
Te Sheng Yang CEO
 Chief Executive Officer - 13/06/18
Ming Tung Kuo CHM
 Chairman - 11/08/09
More insiders

Company Profile

Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.
Sector
Medical Equipment, Supplies & Distribution
Calendar
05/05/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Pegavision Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
517 TWD
Average target price
474.8 TWD
Spread / Average Target
-8.16%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
ESSILORLUXOTTICA Stock EssilorLuxottica
+11.01% 98.12B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-5.00% 17.66B
AUTEK CHINA INC. Stock Autek China Inc.
-15.23% 2.24B
WARBY PARKER INC. Stock Warby Parker Inc.
-11.56% 1.54B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-34.40% 747M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-35.36% 735M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-6.68% 623M
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+27.68% 494M
VISCO VISION INC. Stock Visco Vision Inc.
+19.35% 493M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 6491 Stock
  4. 6491 Stock